IRGM is a risk factor for several inflammatory diseases, yet no direct link to immune regulation had been shown. In this issue of Molecular Cell, Mehto et al. (2019) report that IRGM limits NLRP3 inflammasome activation-by both direct inhibition of NLRP3/ASC oligomerization and selective autophagic destruction of NLRP3/ASC. Immunity-related GTPase M (IRGM) has been of interest to immunologists since a 2007 Wellcome Trust genome-wide association study linked several SNPs near the IRGM locus to Crohn's disease (Wellcome Trust Case Control Consortium, 2007) . Subsequently, IRGM has been associated with a variety of inflammatory diseases including tuberculosis, autoimmune thyroiditis, and ankylosing spondylitis. In each of these cases, IRGM is believed to have a protective function. While early functional studies suggested IRGM as a positive regulator of autophagy (Singh et al., 2006) , it remained unclear whether additional mechanisms exist by which IRGM affects inflammation. In this issue, Mehto et al. (2019) extend the range of IRGM's intracellular functions, mechanistically implicating it in inflammation via regulation of the NLRP3 inflammasome. The authors robustly demonstrate that IRGM inhibits the NLRP3 inflammasome by two distinct mechanisms: (1) IRGM directly binds NLRP3 and impedes its activation by inhibiting its oligomerization and (2) IRGM is involved in the selective autophagic degradation of NLRP3 and ASC.
The NLRP3 inflammasome senses the disruption of cellular homeostasis and assembles upon activation, consisting of the sensor protein NLRP3, the adaptor protein ASC, and caspase-1 (He et al., 2016) . NLRP3 homo-oligomerizes upon activation, which is thought to act as the molecular seed enabling the prion-like formation of ASC fibrils via homotypic ASC-ASC interactions and heterotypic interactions with NLRP3. Interactions between ASC and caspase-1 in the assembled NLRP3 inflammasome promote the autocatalytic activation of caspase-1, resulting in the cleavage and activation of the proinflammatory mediators interleukin-1b (IL-1b) and IL-18. IL-1b and IL-18 are important in the recruitment and activation of innate and adaptive immune cells, rendering the NLRP3 inflammasome a critical mediator of innate immunity. Inflammasome activation also results in pyroptotic (inflammatory) cell death via cleavage of gasdermin D by caspase-1 (Liu et al., 2016) , which contributes to the detrimental effects of excess NLRP3 activation.
In delineating the mechanism by which IRGM limits NLRP3 inflammasome activation, Mehto et al. (2019) used cell lines and human peripheral blood mononuclear cells (PBMCs) to demonstrate that knockdown of IRGM enhanced caspase-1 cleavage and IL-1b release upon activation of the NLRP3 inflammasome. They showed biochemically that IRGM physically interacts with inflammasome components and that it can be visualized over active inflammasomes. Mapping studies showed that IRGM binds to the conserved NACHT domain of NLRP3 and the PYRIN (PYD) domain of ASC, with the former required for the homooligomerization of NLRP3 and the latter needed for NLRP3-ASC and ASC-ASC interactions during inflammasome assembly. Accordingly, crosslinking experiments showed that IRGM inhibits the homo-and hetero-oligomerization of both NLRP3 and ASC without affecting the ASC-caspase-1 interaction.
In addition to the oligomerization defects, the authors noted that IRGM mediated autophagic degradation of NLRP3 and ASC. While established that general autophagic flux decreases ASC levels and IL-1b release by eliminating active in-flammasomes, general autophagic flux is not selective for NLRP3 and inhibits other inflammasomes (Shi et al., 2012) . Mehto et al. (2019) found that IRGM selectively degraded NLRP3, but not AIM2 or NLRC4, indicating the existence of specific mechanisms targeting the NLRP3 inflammasome. Using elegant time-chase imaging experiments, the authors determined that IRGM acts as a scaffold protein, first bringing the autophagy adaptor protein p62 to NLRP3, which then allows the docking of the autophagy initiation protein Beclin-1 and the autophagy elongation protein ATG16L1. Through this sequence of events, IRGM selectively promotes the degradation of NLRP3 inflammasomes. Using the IRGM GTPase activity-deficient mutant, the authors found that autophagic degradation of NLRP3 is GTPase dependent, but inhibition of NLRP3 oligomerization is not. Importantly, the authors confirmed that both identified mechanisms independently contribute to IRGM-mediated NLRP3 inhibition.
NLRP3 has previously been linked to Crohn's disease in experimental models, as too little or too much inflammasome activation exacerbates colitis (Kanneganti, 2017). To functionally validate their biochemical findings and confirm the role of the IRGM-NLRP3 interaction in Crohn's disease, the authors utilized an in vivo dextran-sulfate (DSS)-induced colitis model in Irgm1 À/À mice. Irgm1 À/À mice develop exacerbated inflammatory symptoms compared to wild-type controls after DSS-induced colitis. Inhibition of NLRP3 with the specific inhibitor MCC950 rescued the intensified symptoms in Irgm1 À/À mice, strongly suggesting that aberrant NLRP3 activity in IRGM-deficient settings drives gut inflammation in models of colitis.
The study from Mehto et al. (2019) raises several interesting lines of future investigation. The central role of NLRP3 in propagation of inflammation makes it an attractive drug target, with several NLRP3 inhibitors identified and tested preclinically (Mangan et al., 2018) . Despite this, the molecular targets and biochemical interactions mediating NLRP3 inhibition remain unclear. Further structural and biochemical investigation of the IRGM/ASC/NLRP3 interaction may provide insight into important motifs mediating NLRP3 oligomerization and could aid in the development of small molecules specifically targeting critical NLRP3 sites.
Additionally, studies investigating mechanisms regulating IRGM levels are warranted. While murine homologs of IRGM are interferon inducible, the IRGM gene was inactivated early in primate evolution due to a retrotransposon event that disrupted the open reading frame. The gene was reestablished in a common ancestor of hu-mans and great apes due to an ERV9 retroviral insertion at the 5 0 end of the IRGM gene (Bekpen et al., 2009) . Considering the link between IRGM and NLRP3, understanding mechanisms regulating IRGM levels may provide insight into the inflammatory process. Finally, as NLRP3 dysregulation has been implicated in the pathogenesis of several chronic inflammatory diseases, therapeutic strategies targeting the IRGM-NLRP3 interaction could be useful for a variety of diseases with inflammatory etiologies.
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